author-photo

Junichi Hisatake

University of California, Los Angeles

6

Papers

242

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR(4.5) ): The phase 2, multicenter N-Road study.

2020 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (1)
HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

2000 Blood
Show All
- Source
- Cite
- Save
Citations (49)
PC‐SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo

2000 The Prostate
Show All
- Source
- Cite
- Save
Citations (78)